Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (41-50 of 496) with videos related to

Pageof 50
Sort By:
Clinical Epigenetics|June 19, 2012
Histone deacetylases in viral infectionsGeorges Herbein, Daniel Wendling
Nature Reviews. Rheumatology|February 24, 2017
Spondyloarthropathies: Fine tuning the management of axial spondyloarthritisDaniel Wendling, Clément Prati
Expert Opinion on Pharmacotherapy|March 12, 2004
The use of TNF-alpha blocking agents in rheumatoid arthritis: an overviewEric Toussirot, Daniel Wendling
Expert Review of Clinical Immunology|June 5, 2013
Spondyloarthritis and smoking: towards a new insight into the diseaseDaniel Wendling, Clément Prati
Joint Bone Spine|April 10, 2013
New bone formation in axial spondyloarthritisDaniel Wendling, Pascal Claudepierre
Joint Bone Spine|July 7, 2014
Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritisJulien Paccou, Daniel Wendling
The Journal of Rheumatology|September 3, 2017
Spondyloarthritis: Harlequin or Chameleon?Daniel Wendling, Clément Prati
The Journal of Rheumatology|December 7, 2005
Bacillus calmette-guérin vaccination in a patient treated with infliximabEric Toussirot, Daniel Wendling
Expert Opinion on Biological Therapy|June 13, 2020
From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibitionDaniel Wendling, Philippe Goupille
Joint Bone Spine|June 14, 2020
Toward a tailored therapeutic prescription for patients with axial spondyloarthritisPhilippe Goupille, Daniel Wendling
Pageof 50

Showing results (41-50 of 496) with videos related to

Sort By:
Pageof 50
Clinical Epigenetics|June 19, 2012
Histone deacetylases in viral infectionsGeorges Herbein, Daniel Wendling
Nature Reviews. Rheumatology|February 24, 2017
Spondyloarthropathies: Fine tuning the management of axial spondyloarthritisDaniel Wendling, Clément Prati
Expert Opinion on Pharmacotherapy|March 12, 2004
The use of TNF-alpha blocking agents in rheumatoid arthritis: an overviewEric Toussirot, Daniel Wendling
Expert Review of Clinical Immunology|June 5, 2013
Spondyloarthritis and smoking: towards a new insight into the diseaseDaniel Wendling, Clément Prati
Joint Bone Spine|April 10, 2013
New bone formation in axial spondyloarthritisDaniel Wendling, Pascal Claudepierre
Joint Bone Spine|July 7, 2014
Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritisJulien Paccou, Daniel Wendling
The Journal of Rheumatology|September 3, 2017
Spondyloarthritis: Harlequin or Chameleon?Daniel Wendling, Clément Prati
The Journal of Rheumatology|December 7, 2005
Bacillus calmette-guérin vaccination in a patient treated with infliximabEric Toussirot, Daniel Wendling
Expert Opinion on Biological Therapy|June 13, 2020
From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibitionDaniel Wendling, Philippe Goupille
Joint Bone Spine|June 14, 2020
Toward a tailored therapeutic prescription for patients with axial spondyloarthritisPhilippe Goupille, Daniel Wendling
Pageof 50